Onyx Pharmaceuticals Inc (NASDAQ:ONXX)

95.23
Data as of May 24
 -0.97 / -1.01%
Today’s Change
41.26
Today|||52-Week Range
101.57
+26.08%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$7.0B

Company Description

Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company, which engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company focuses on developing novel medicines that target key molecular pathways in cancers, with the goal of extending and enhancing the lives of patients. Its portfolio comprises of two oncology franchises focused on kinase inhibition and proteasome inhibition, and includes approved therapies in solid and hematological malignances. The company was founded by Frank McCormick in February 1992 and is headquartered in South San Francisco, CA.

Contact Information

Onyx Pharmaceuticals, Inc.
249 East Grand Avenue
South San Francisco California 94080
P:(650) 266-0000
Investor Relations:
(650) 266-2114

Employees

Shareholders

Mutual fund holders63.48%
Other institutional41.97%
Individual stakeholders1.07%

Top Executives

N. Anthony Coles, Jr., MDChairman, President & Chief Executive Officer
Matthew K. Fust, MBAChief Financial Officer & Executive Vice President
Pablo J. Cagnoni, MDExecutive VP-Global Research & Development
Suzanne M. ShemaSecretary, Executive VP & General Counsel
Helen I. Torley, MDChief Commercial Officer & Executive VP

To view my watchlist

Not a member yet?

Sign up now for a free account

jobs by SimplyHired

Search for jobs

Search All Jobs from Across the Web

Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2013 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2013 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2013. All rights reserved. Most stock quote data provided by BATS.